Cargando…
Treatment of primary eosinophilic colitis using immunoglobulin/histamine complex
Primary eosinophilic colitis (PEC) is a primary eosinophilic gastrointestinal disorder, and immunoglobulin/histamine complex (IHC) may be an effective therapeutic for PEC. IHC has a nonallergen‐specific antinociceptive effect in the treatment of histamine‐mediated pain.
Autores principales: | Kim, Hyuk Soon, Noh, Geunwoong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860130/ https://www.ncbi.nlm.nih.gov/pubmed/36698523 http://dx.doi.org/10.1002/ccr3.6885 |
Ejemplares similares
-
Induction of remission in chronic urticaria by immunotherapy using immunoglobulin/histamine complex (Histobulin™): a case report
por: Kim, Hyuk Soon, et al.
Publicado: (2021) -
Effects of the immunoglobulin/histamine complex on panic disorder concurrent with chronic spontaneous urticaria: a case report
por: Kim, Hyuk Soon, et al.
Publicado: (2023) -
Immunotherapy using Histobulin™ in psoriasis: A case report
por: Kim, Hyuk Soon, et al.
Publicado: (2022) -
Immunotherapy using Histobulin in atopic dermatitis
por: Noh, Geunwoong
Publicado: (2020) -
Histobulin as a complementary but essential therapeutic for Intravenous Immune Globulin Therapy of Pfeiffer‐Weber‐Christian disease with multiple allergic diseases and its effects on allergic disease: A case report
por: Noh, Geunwoong
Publicado: (2020)